IOSP
IOSP
NASDAQ · Chemicals

Innospec Inc

$82.73
-0.38 (-0.46%)
Financial Highlights (FY 2026)
Revenue
1.67B
Net Income
109.79M
Gross Margin
27.7%
Profit Margin
6.6%
Rev Growth
-3.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 27.7% 27.7% 47.6% 47.6%
Operating Margin 7.3% 6.6% 11.9% 13.3%
Profit Margin 6.6% 6.2% 10.5% 9.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.67B 1.73B 1.16B 1.31B
Gross Profit 463.57M 479.19M 550.75M 621.95M
Operating Income 121.88M 113.39M 137.91M 173.27M
Net Income 109.79M 102.14M 121.69M 129.51M
Gross Margin 27.7% 27.7% 47.6% 47.6%
Operating Margin 7.3% 6.6% 11.9% 13.3%
Profit Margin 6.6% 6.2% 10.5% 9.9%
Rev Growth -3.3% -3.3% +1.1% -8.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 175.29M 181.16M
Total Equity 1.11B 1.03B
D/E Ratio 0.16 0.18
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 131.26M 128.90M 208.77M 249.95M
Free Cash Flow 164.95M 158.97M